Utilization of alpha blocker medications post transurethral resection of prostate (TURP)
Abstract
The aims To evaluate the exact role of alpha blocker use for treatment of persistent LUTS after TURP. Methods This is a narrative review of existing manuscripts regarding the alpha blockers use after TURP. The search was done through PubMed in June 2021. The search was conducted using the following key words” alpha blocker” AND “after transurethral prostatectomy”. Results Publications between 2000 and 2020 were reviewed using PubMed database search. 111 studies were found. Seven records were considered for this review. Surgery for BPH is successful in eliminating the need for medical therapy in 75% in patients who use medications before surgery. However, number of patients still have persistent LUTS after TURP. There are no guidelines to direct the management of LUTS after TURP. A little research regarding the outcomes of alpha blockers use for treatment of persistent LUTS after TURP are detected. Based on the studies, theoretical basis exists for using of alpha blockers to treat post TURP urinary symptoms. Conclusion Alpha blockers can be used for treatment of post TURP urinary symptoms whether they are a continuation or de novo. Further large studies are needed.
Read the paper
Related studies
- Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling
- Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
- Luteolin Inhibits Dexamethasone‐Induced Osteoporosis by Autophagy Activation Through miR‐125b‐5p/SIRT3/AMPK/mTOR Axis, an In Vitro and In Vivo Study
- Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes
- Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI‐RS 2023
- Chylomicron-mimicking supramolecular nano emulsion for oral luteolin delivery against hyperuricemia
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.